0001662579-23-000107.txt : 20231003 0001662579-23-000107.hdr.sgml : 20231003 20231003162638 ACCESSION NUMBER: 0001662579-23-000107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231002 FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GROGAN DONNA ROY CENTRAL INDEX KEY: 0001788455 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39567 FILM NUMBER: 231304116 MAIL ADDRESS: STREET 1: 1133 OLD QUEEN ANNE ROAD CITY: CHATHAM STATE: MA ZIP: 02633 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: C4 Therapeutics, Inc. CENTRAL INDEX KEY: 0001662579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475617627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 231-0700 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 wk-form4_1696364777.xml FORM 4 X0508 4 2023-10-02 0 0001662579 C4 Therapeutics, Inc. CCCC 0001788455 GROGAN DONNA ROY C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #120 WATERTOWN MA 02472 1 0 0 0 0 Common Stock 2023-10-02 4 A 0 8089 1.70 A 19827 D These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 2, 2023. /s/ Jolie M. Siegel, Attorney-in-Fact 2023-10-03